Dr. Jennifer McVean, MD, is a nationally recognized pediatric endocrinologist and diabetes specialist committed to enhancing the lives of children and families affected by diabetes and endocrine disorders. Currently serving as Senior Director of Medical Affairs for Medtronic Diabetes, Dr. McVean has dedicated nearly two decades to advancing pediatric diabetes care through clinical practice, research, education, and medical innovation.
Diagnosed with Type 1 diabetes at the age of 11, Dr. McVean brings a unique perspective to patient care, combining her personal experience with extensive medical expertise. This firsthand understanding has shaped her compassionate approach to helping children and families navigate the challenges of chronic disease management.
Dr. McVean earned her medical degree from the University of Minnesota Medical School, completed her pediatric residency at the University of Colorado, and pursued a fellowship in Pediatric Endocrinology and Diabetes at the University of Wisconsin. She is board-certified in Pediatrics and Pediatric Endocrinology.
Throughout her career, Dr. McVean has held leadership, academic, and clinical positions with esteemed healthcare organizations, including the University of Minnesota, Children’s Minnesota, Gundersen Health System, Hudson Physicians, and Medtronic Diabetes. Her areas of specialization encompass Type 1 Diabetes, pediatric diabetes management, insulin pump therapy, continuous glucose monitoring (CGM), growth disorders, thyroid disorders, pediatric endocrinology, diabetes technology and innovation, and clinical research and medical affairs leadership.
Dr. McVean’s work has significantly contributed to advancements in automated insulin delivery systems, diabetes technology adoption, and improved outcomes for pediatric patients worldwide. Notably, she has been involved in studies demonstrating the benefits of using automated insulin delivery systems as first-line treatment for Type 1 diabetes, which have shown promise in prolonging the ‘honeymoon phase’ of the disease.
Actively engaged in numerous diabetes advocacy and educational organizations, Dr. McVean has collaborated with the Juvenile Diabetes Research Foundation (JDRF), the American Diabetes Association (ADA), ADA Camp Needlepoint, the TrialNet Research Network, and the Pediatric Endocrine Society. Her dedication extends to mentoring, research, education, and community outreach focused on improving diabetes awareness, prevention, and treatment.
Through her clinical leadership, research contributions, and work in medical technology, Dr. Jennifer McVean continues to influence the future of diabetes care worldwide. Her mission remains focused on helping individuals with diabetes achieve healthier, more independent lives while advancing innovations that reduce the burden of disease for future generations.
Dr. Jennifer McVean has become a respected voice in the Type 1 Diabetes community through her leadership, advocacy, and commitment to advancing diabetes care. Living with Type 1 Diabetes herself, Dr. McVean brings both personal experience and medical expertise to the search for better treatments and, ultimately, a cure.
Her work has helped accelerate awareness of emerging disease-modifying therapies, early detection programs, advanced insulin delivery systems, and next-generation cell-based treatments that are changing the future of Type 1 Diabetes care. Researchers worldwide are now making significant progress toward therapies that may delay, prevent, or one day eliminate the need for lifelong insulin dependence.
As a physician, educator, and advocate, Dr. McVean continues to support groundbreaking research efforts aimed at preserving insulin-producing cells, improving quality of life, and moving the medical community closer to a world without Type 1 Diabetes. While no definitive cure has yet been approved, the pace of innovation has never been greater, and leaders like Dr. McVean are helping drive that progress forward.
To learn more about Dr. Jennifer McVean and her work, visit her profile at Hudson Physicians.